- Home
- HALO vs BIRK Comparison
HALO vs BIRK Comparison
Compare HALO & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HALO
- BIRK
- Stock Information
- Founded
- HALO 1998
- BIRK 1774
- Country
- HALO United States
- BIRK United Kingdom
- Employees
- HALO N/A
- BIRK N/A
- Industry
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- BIRK
- Sector
- HALO Health Care
- BIRK
- Exchange
- HALO Nasdaq
- BIRK Nasdaq
- Market Cap
- HALO 9.0B
- BIRK 8.8B
- IPO Year
- HALO N/A
- BIRK 2023
- Fundamental
- Price
- HALO $65.56
- BIRK $44.58
- Analyst Decision
- HALO Buy
- BIRK Strong Buy
- Analyst Count
- HALO 10
- BIRK 12
- Target Price
- HALO $73.40
- BIRK $68.08
- AVG Volume (30 Days)
- HALO 2.2M
- BIRK 2.4M
- Earning Date
- HALO 10-30-2025
- BIRK 08-14-2025
- Dividend Yield
- HALO N/A
- BIRK N/A
- EPS Growth
- HALO 68.93
- BIRK 178.47
- EPS
- HALO 4.37
- BIRK 1.92
- Revenue
- HALO $1,178,672,000.00
- BIRK $2,380,334,704.00
- Revenue This Year
- HALO $32.57
- BIRK $18.03
- Revenue Next Year
- HALO $23.25
- BIRK $14.32
- P/E Ratio
- HALO $15.12
- BIRK $22.99
- Revenue Growth
- HALO 34.97
- BIRK 17.60
- 52 Week Low
- HALO $42.01
- BIRK $40.56
- 52 Week High
- HALO $79.50
- BIRK $62.66
- Technical
- Relative Strength Index (RSI)
- HALO 31.20
- BIRK 37.02
- Support Level
- HALO $73.06
- BIRK $43.95
- Resistance Level
- HALO $76.30
- BIRK $46.96
- Average True Range (ATR)
- HALO 2.33
- BIRK 1.50
- MACD
- HALO -1.57
- BIRK 0.03
- Stochastic Oscillator
- HALO 3.81
- BIRK 33.89
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
About BIRK Birkenstock Holding plc
Birkenstock Holding PLC is a company that manufactures and sells footbed-based products, including sandals, closed-toe silhouettes, and other products, such as skincare and accessories, for everyday, leisure, and work. It sells its products through two main channels: business-to-business (B2B) which comprises sales made to established third-party store networks, and direct-to-consumer (DTC) which comprises sales made on globally owned online stores through the Birkenstock.com domain and sales made in Birkenstock retail stores. The company's reportable segments are based on its regional hubs and include: the Americas which is also its key revenue-generating segment; Europe; and Australia, Japan, India, China, and the United Arab Emirates (APMA).